Yahoo
    HKSE - Delayed Quote HKD

    Zai Lab Limited (9688.HK)

    17.370 -0.310 (-1.75%)
    At close: October 30 at 4:08:07 PM GMT+8
    Loading Chart for 9688.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Zai Lab Limited (ZLAB) Gains EMA Orphan Drug Designation for DLL3-Targeting Cancer Therapy

    Zai Lab Limited (ZLAB) Gains EMA Orphan Drug Designation for DLL3-Targeting Cancer Therapy
    Insider Monkey 3mo ago
    Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas

    Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas
    Business Wire 4mo ago
    Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

    Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
    Business Wire 4mo ago
    Zai Lab (ZLAB) Is Down 6.0% After Leadership Shake-Up And 2026 Data Focus Has The Bull Case Changed?

    Zai Lab (ZLAB) Is Down 6.0% After Leadership Shake-Up And 2026 Data Focus Has The Bull Case Changed?
    Simply Wall St. 4mo ago
    Zai Lab Q1 Earnings Call Highlights

    Zai Lab Q1 Earnings Call Highlights
    MarketBeat 5mo ago
    Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

    Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say
    Zacks 5mo ago
    Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset

    Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset
    Simply Wall St. 5mo ago
    Zai Lab Showcases 54% Brain Metastases Response for ZL-1310 ADC in SCLC at AACR Investor Call

    Zai Lab Showcases 54% Brain Metastases Response for ZL-1310 ADC in SCLC at AACR Investor Call
    MarketBeat 6mo ago
    Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy

    Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy
    Insider Monkey 6mo ago
    Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

    Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
    PREMIUM
    MT Newswires 6mo ago
    JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why

    JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why
    Insider Monkey 6mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: